Tpl2 Kinase Inhibitor 1
Based on 1 publication(s) in Google Scholar
Tpl2 Kinase Inhibitor 1 is a 3-pyridylmethylamino analog, and is a selective Tpl2 inhibitor (IC50=50 nM). Tpl2 consists of COT kinase and MAP3K8. Tpl2 Kinase Inhibitor 1 plays an important role in the regulation of the inflammatory response and the progression of some cancers.
For research use only. We do not sell to patients.
- Purity: 99.42%
- CAS No.: 871307-18-5
- Formula: C21H14ClFN6
- Molecular Weight:404.83
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) Tpl2 Kinase Inhibitor 1
MoreAll MAP3K Isoforms
More
Biological Activity
|
MAP3K8/COT/Tpl2 |
p38 180 μM (IC50) |
MK2 110 μM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-431 | IC50 |
<5 μM
Compound: 1b
|
Inhibition of EGFR kinase autophosphorylation in A431 cells
Inhibition of EGFR kinase autophosphorylation in A431 cells
|
[PMID: 17664070] |
| Monocyte | IC50 |
1.1 μM
Compound: 1b
|
Inhibition of LPS-induced TNFalpha production in human monocytes
Inhibition of LPS-induced TNFalpha production in human monocytes
|
[PMID: 17664070] |
Tpl2 (Cot/MAP3K8) is a serine/threonine kinase in the MAP3K family that is upstream of MEK in the ERK pathway[1].
Tpl2 Kinase Inhibitor 1 (compound 2p) also inhibits MK2 and p38, with IC50s of 110 μM and 180 μM, respectively in A431 cells[1].
Tpl2 Kinase Inhibitor 1 inhibits lipopolysaccharide-induced TNF-a production from primary human monocytes and human whole-blood, with IC50s of 0.7 μM and 8.5 μM, respectively[1].
Cancer Osaka thyroid (COT) kinase (Tpl2) is an important regulator of pro-inflammatory cytokines in macrophages[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 871307-18-5
-
Appearance Solid
-
Molecular Weight 404.83
-
Formula C21H14ClFN6
-
Color Yellow to green
-
SMILES
N#CC1=C(NC2=CC=C(F)C(Cl)=C2)C3=CC(NCC4=CC=CN=C4)=NC=C3N=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Phytomedicine
Astragaloside Ⅳ negatively regulates Gpr97-TPL2 signaling to protect against hyperhomocysteine-exacerbated sepsis associated acute kidney injury. [Abstract]2024 Mar:125:155346. PMID: 38237511
Solvent & Solubility
DMSO : 100 mg/mL (247.02 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (274 KB)
-
SDS (392 KB)
- English - EN (392 KB)
- Français - FR (392 KB)
- Deutsch - DE (392 KB)
- Norwegian - NO (392 KB)
- Español - ES (392 KB)
- Swedish - SV (392 KB)
- Italian - IT (392 KB)
- Portuguese - PT (392 KB)
-
Handling Instructions (2659 KB)
References
[1]. Gavrin LK, et al. Inhibition of Tpl2 kinase and TNF-alpha production with 1,7-naphthyridine-3-carbonitriles: synthesis and structure-activity relationships. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5288-92. [Content Brief]
[2]. Glatthar R, et al. Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors. J Med Chem. 2016 Aug 25;59(16):7544-60. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.4702 mL | 12.3509 mL | 24.7017 mL | 61.7543 mL |
| 5 mM | 0.4940 mL | 2.4702 mL | 4.9403 mL | 12.3509 mL | |
| 10 mM | 0.2470 mL | 1.2351 mL | 2.4702 mL | 6.1754 mL | |
| 15 mM | 0.1647 mL | 0.8234 mL | 1.6468 mL | 4.1170 mL | |
| 20 mM | 0.1235 mL | 0.6175 mL | 1.2351 mL | 3.0877 mL | |
| 25 mM | 0.0988 mL | 0.4940 mL | 0.9881 mL | 2.4702 mL | |
| 30 mM | 0.0823 mL | 0.4117 mL | 0.8234 mL | 2.0585 mL | |
| 40 mM | 0.0618 mL | 0.3088 mL | 0.6175 mL | 1.5439 mL | |
| 50 mM | 0.0494 mL | 0.2470 mL | 0.4940 mL | 1.2351 mL | |
| 60 mM | 0.0412 mL | 0.2058 mL | 0.4117 mL | 1.0292 mL | |
| 80 mM | 0.0309 mL | 0.1544 mL | 0.3088 mL | 0.7719 mL | |
| 100 mM | 0.0247 mL | 0.1235 mL | 0.2470 mL | 0.6175 mL |